Welcome to our dedicated page for Standex Intl SEC filings (Ticker: SXI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Standex International Corporation (NYSE: SXI) SEC filings page provides access to the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. These filings offer detailed insight into Standex’s financial performance, governance practices, executive compensation, and shareholder matters.
Standex submits a variety of forms, including Form 8-K current reports and its DEF 14A definitive proxy statement. Recent Form 8-K filings have covered topics such as the announcement of quarterly earnings, the results of the Annual Meeting of Shareholders, and changes in executive roles. Through these reports, investors can review information on segment performance across Electronics, Engineering Technologies, Scientific, Engraving, and Specialty Solutions, as well as commentary on revenue, margins, and capital allocation.
The company’s definitive proxy statement describes board leadership structure, board committees, strategy and risk oversight, ESG strategy and risks, director compensation, director independence, and stock ownership. It also details the items presented to shareholders for voting, including director elections, advisory votes on executive compensation, and ratification of the independent auditors.
On this page, filings are updated as they are made available on EDGAR. AI-powered tools summarize key points from lengthy documents, helping users quickly identify topics such as shareholder vote outcomes, executive compensation disclosures, and significant corporate events reported on Form 8-K. Investors can use these summaries alongside the full-text filings to better understand Standex’s regulatory reporting and governance framework.
Standex International Vice President, CFO and Treasurer Ademir Sarcevic reported a tax-related share disposition. On April 1, 2026, 1,713 shares of common stock were forfeited at $260.09 per share to cover taxes on vesting of previously issued restricted stock. After this withholding, he directly holds 7,628 shares of Standex common stock.
Standex International director Thomas E. Chorman reported an open-market sale of 50 shares of Common Stock at $257.94 per share on April 1, 2026. The transaction was executed pursuant to an existing Rule 10b5-1 trading plan dated November 6, 2025.
After this sale, Chorman directly holds 12,566 shares of Standex International common stock, indicating the transaction represents a small portion of his reported holdings and appears to be a routine, pre-planned sale.
Fidelity Brokerage Services LLC submitted a Form 144-style notice reporting transactions in Common stock. The filing lists a 50-share restricted stock vesting event dated 10/26/2024 and three reported sales by Thomas Chorman on 02/04/2026 (50 shares), 02/27/2026 (513 shares), and 03/02/2026 (50 shares).
Standex International Corp — Amendment No. 16 to a Schedule 13G/A states that The Vanguard Group reports 0 shares beneficially owned, equal to 0% of common stock. The filing attributes this to an internal realignment on January 12, 2026 that disaggregated certain Vanguard subsidiaries, which now report separately. The form is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
Standex International director Thomas E. Chorman reported an open-market sale of 50 shares of Standex International common stock at $259 per share on March 2, 2026. The sale was made under an existing Rule 10b5-1 trading plan dated November 6, 2025, and he now holds 12,616 shares directly.
Standex International director Thomas E. Chorman reported an open-market sale of 513 shares of common stock at $260 per share on February 27, 2026. After this transaction, he directly owns 12,666 shares of Standex International common stock.
SXI reports a Form 144 notice showing proposed and recent sales of common stock by an insider. The filing lists proposed sale activity associated with an account at Fidelity Brokerage Services LLC and records prior dispositions by Thomas Chorman on 02/04/2026 and 02/27/2026.
The excerpt shows a proposed lot of 50 common shares linked to Fidelity and two past sales of 50 and 513 shares by Mr. Chorman on the dates above. Transaction pricing and net proceeds are included in the excerpt as numeric entries adjacent to each row.
SXI submitted a Form 144 notice listing 133,380.00 common shares associated with Fidelity Brokerage Services LLC.
The filing records a reported sale of 50 common shares by Thomas Chorman on 02/04/2026 and lists restricted stock vesting entries of 218 and 295 shares with vesting dates of 10/26/2024 and 10/25/2025.
Standex International director Barbara Joanne Edwards reported a charitable-type move involving company stock. On February 23, 2026, she transferred 58 shares of Standex International common stock as a bona fide gift with no consideration received. After this gift transfer, she directly owned 6,227 common shares of Standex International.
Standex International director Charles H. Cannon Jr. reported an open-market sale of 2,000 shares of common stock at $256.64 per share. The shares were held indirectly as Trustee of a Trust, which reported 13,046 shares remaining after the sale. Separately, Cannon reported 2,280 shares of common stock held directly, with this line reflecting a reported holding rather than a new transaction.